BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22991452)

  • 1. Mate pair sequencing of whole-genome-amplified DNA following laser capture microdissection of prostate cancer.
    Murphy SJ; Cheville JC; Zarei S; Johnson SH; Sikkink RA; Kosari F; Feldman AL; Eckloff BW; Karnes RJ; Vasmatzis G
    DNA Res; 2012 Oct; 19(5):395-406. PubMed ID: 22991452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage relationship of Gleason patterns in Gleason score 7 prostate cancer.
    Kovtun IV; Cheville JC; Murphy SJ; Johnson SH; Zarei S; Kosari F; Sukov WR; Karnes RJ; Vasmatzis G
    Cancer Res; 2013 Jun; 73(11):3275-84. PubMed ID: 23695551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliable detection of somatic mutations in solid tissues by laser-capture microdissection and low-input DNA sequencing.
    Ellis P; Moore L; Sanders MA; Butler TM; Brunner SF; Lee-Six H; Osborne R; Farr B; Coorens THH; Lawson ARJ; Cagan A; Stratton MR; Martincorena I; Campbell PJ
    Nat Protoc; 2021 Feb; 16(2):841-871. PubMed ID: 33318691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications.
    Sho S; Court CM; Winograd P; Lee S; Hou S; Graeber TG; Tseng HR; Tomlinson JS
    BMC Cancer; 2017 Jul; 17(1):457. PubMed ID: 28666423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of whole genome amplification to study chromosomal changes in prostate cancer: insights into genome-wide signature of preneoplasia associated with cancer progression.
    Hughes S; Yoshimoto M; Beheshti B; Houlston RS; Squire JA; Evans A
    BMC Genomics; 2006 Mar; 7():65. PubMed ID: 16573809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
    Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
    Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of whole genome amplification and comparative genomic hybridisation to detect chromosomal copy number alterations in cell line material and tumour tissue.
    Hughes S; Lim G; Beheshti B; Bayani J; Marrano P; Huang A; Squire JA
    Cytogenet Genome Res; 2004; 105(1):18-24. PubMed ID: 15218253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of whole genome amplified (WGA) DNA for use in genotyping assay development.
    Han T; Chang CW; Kwekel JC; Chen Y; Ge Y; Martinez-Murillo F; Roscoe D; Težak Z; Philip R; Bijwaard K; Fuscoe JC
    BMC Genomics; 2012 Jun; 13():217. PubMed ID: 22655855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in array comparative genomic hybridization for the analysis of cancer samples.
    Nowak NJ; Miecznikowski J; Moore SR; Gaile D; Bobadilla D; Smith DD; Kernstine K; Forman SJ; Mhawech-Fauceglia P; Reid M; Stoler D; Loree T; Rigual N; Sullivan M; Weiss LM; Hicks D; Slovak ML
    Genet Med; 2007 Sep; 9(9):585-95. PubMed ID: 17873646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.
    Murphy SJ; Karnes RJ; Kosari F; Castellar BE; Kipp BR; Johnson SH; Terra S; Harris FR; Halling GC; Klein JL; Nasir A; Bergstrahl E; Rangel LJ; Sukov WR; Vasmatzis G; Cheville JC
    Mod Pathol; 2016 Feb; 29(2):143-56. PubMed ID: 26612463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins.
    Lindberg J; Klevebring D; Liu W; Neiman M; Xu J; Wiklund P; Wiklund F; Mills IG; Egevad L; Grönberg H
    Eur Urol; 2013 Feb; 63(2):347-53. PubMed ID: 22502944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.
    Arriola E; Lambros MB; Jones C; Dexter T; Mackay A; Tan DS; Tamber N; Fenwick K; Ashworth A; Dowsett M; Reis-Filho JS
    Lab Invest; 2007 Jan; 87(1):75-83. PubMed ID: 17170740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Optimised Protocol Harnessing Laser Capture Microdissection for Transcriptomic Analysis on Matched Primary and Metastatic Colorectal Tumours.
    Ong CJ; Tan QX; Lim HJ; Shannon NB; Lim WK; Hendrikson J; Ng WH; Tan JWS; Koh KKN; Wasudevan SD; Ng CCY; Rajasegaran V; Lim TKH; Ong CK; Kon OL; Teh BT; Tan GHC; Chia CS; Soo KC; Teo MCC
    Sci Rep; 2020 Jan; 10(1):682. PubMed ID: 31959771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analyses.
    Aaltonen KE; Ebbesson A; Wigerup C; Hedenfalk I
    BMC Res Notes; 2011 Mar; 4():69. PubMed ID: 21418556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Performance of Whole Genome Amplification Methods and Next-Generation Sequencing for Pre-Implantation Genetic Diagnosis of Chromosomal Abnormalities.
    Li N; Wang L; Wang H; Ma M; Wang X; Li Y; Zhang W; Zhang J; Cram DS; Yao Y
    J Genet Genomics; 2015 Apr; 42(4):151-9. PubMed ID: 25953353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods.
    Deleye L; Gansemans Y; De Coninck D; Van Nieuwerburgh F; Deforce D
    PLoS One; 2018; 13(4):e0196334. PubMed ID: 29698522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Copy number variant analysis using genome-wide mate-pair sequencing.
    Smadbeck JB; Johnson SH; Smoley SA; Gaitatzes A; Drucker TM; Zenka RM; Kosari F; Murphy SJ; Hoppman N; Aypar U; Sukov WR; Jenkins RB; Kearney HM; Feldman AL; Vasmatzis G
    Genes Chromosomes Cancer; 2018 Sep; 57(9):459-470. PubMed ID: 29726617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.
    Seed G; Yuan W; Mateo J; Carreira S; Bertan C; Lambros M; Boysen G; Ferraldeschi R; Miranda S; Figueiredo I; Riisnaes R; Crespo M; Rodrigues DN; Talevich E; Robinson DR; Kunju LP; Wu YM; Lonigro R; Sandhu S; Chinnaiyan AM; de Bono JS
    Clin Cancer Res; 2017 Oct; 23(20):6070-6077. PubMed ID: 28751446
    [No Abstract]   [Full Text] [Related]  

  • 20. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.